When the No Surprises Act took effect in January 2022, the industry response was immediate and, in many cases, reactive.
Most of the attention focused on what providers could no longer do. Balance billing protections were expanded. Patient responsibility was capped in specific scenarios. Payment pathways were redirected away from patients and toward payers. For many out-of-network providers, this felt like a direct compression of revenue.
That interpretation was not entirely wrong, but it was incomplete. The law did not eliminate out-of-network reimbursement opportunities, it only restructured it.
Before the NSA, a significant portion of financial leverage sat in the ability to bill patients for the difference between charges and payer reimbursement. That dynamic created variability, but it also gave providers a degree of control, particularly in high-acuity cases where network limitations were evident.
The NSA removed that mechanism in major scenarios. In its place, it introduced a formalized process for determining payment between providers and payers. This includes defined timelines, structured negotiation, and a binding arbitration pathway through Independent Dispute Resolution.
In other words, the law replaced informal leverage with structured leverage.
This distinction matters.
Providers who approach the NSA as a compliance requirement often experience it as a constraint. But, those who approach it as a framework for negotiation begin to see where control still exists.
What the No Surprises Act actually changed
At its core, the no surprise billing act was designed to protect patients from unexpected financial exposure. It does this by removing the patient from the center of out-of-network payment disputes in certain situations.
The most important changes fall into three areas.
Balance billing restrictions
The NSA prohibits balance billing in specific scenarios, including:
Emergency services, regardless of where they are delivered
Non-emergency services provided at in-network facilities by out-of-network clinicians
Certain ancillary services, such as anesthesia, radiology, and pathology
In these cases, patients are only responsible for in-network cost-sharing amounts. Providers can no longer bill patients for the remaining balance.
Payment responsibility shifted to payers
Under the no surprise act medical billing rules, providers must now seek reimbursement directly from the payer.
This changes the dynamic in a meaningful way. Instead of relying on patient billing as a fallback, providers must engage payers through a defined process that determines what will ultimately be paid.
Introduction of a structured payment process
The NSA established a standardized sequence for resolving out-of-network payments:
The provider submits a claim
The payer issues an initial payment or denial
A 30-day open negotiation period begins
If unresolved, either party can initiate Independent Dispute Resolution
This structure formalizes what was previously inconsistent and often opaque.
The role of the qualifying payment amount
One of the most debated elements of the NSA is the Qualifying Payment Amount, or QPA.
The QPA is defined as the median in-network rate a payer has contracted for a given service within a geographic region. It is used as a reference point during payment discussions and within the dispute resolution process.
Early regulatory guidance placed heavy emphasis on the QPA, which raised concerns across the provider community. Many viewed it as a mechanism that would anchor reimbursement to payer-defined benchmarks, regardless of case complexity.
Subsequent rulemaking clarified that the QPA is one factor among several. Arbitrators are expected to consider additional elements such as:
The provider’s training and experience
The complexity of the service
The acuity of the patient
Market conditions and prior contracting history
Despite this clarification, the QPA continues to influence payer behavior.
In practice, it often serves as an anchor point in negotiations. Providers who do not actively build a case beyond that anchor often see reimbursement align closely with it.
Independent dispute resolution and how outcomes are decided
The Independent Dispute Resolution process is where payment disagreements are formally resolved.
It follows a structured model often referred to as “baseball-style” arbitration. Both the provider and the payer submit a final offer. An independent reviewer selects one of the two. There is no middle ground.
This format changes how cases need to be built.
Success in IDR depends on the ability to present a clear, well-supported position. Arbitrators evaluate the credibility of each submission, including how well it accounts for the factors outlined in the law.
Strong submissions typically include:
Detailed clinical context that supports the level of care provided
Evidence of case complexity and acuity
Market data that supports the proposed reimbursement
Documentation that differentiates the case from standard scenarios
Weak submissions rely on generalized arguments or default to charges without supporting context. The process is structured, but it is not neutral. Outcomes reflect how effectively each side presents its position.
For providers, this represents a change. Reimbursement is no longer shaped through informal negotiation or patient billing, it is determined through a defined, evidence-based process.
Does the no surprises act apply to physician offices
A common question we see at Valedo is whether the NSA applies broadly across all care settings.
In most cases, it does not apply to typical physician office encounters.
The law primarily governs:
Emergency services
Care delivered at in-network facilities
Ancillary services where patients do not control provider selection
Physician offices operating independently, particularly in elective or scheduled care, are generally outside the scope of these restrictions.
However, there are important nuances.
If services are connected to facility-based care or fall within scenarios covered by the NSA, the rules may still apply. Providers need to understand where those boundaries exist, especially when care spans multiple settings.
This distinction is important from a strategic standpoint. It defines where traditional out-of-network dynamics still operate and where the NSA framework takes over.
Where providers are getting squeezed
The pressure many providers feel under the NSA is not solely a function of the law itself, as it often reflects how the law is being approached.
Several patterns have since cropped up.
Providers rely heavily on IDR without strengthening their pre-service position.
Submissions are built around charges rather than supported by clinical and market context.
The QPA is treated as an unavoidable outcome rather than a reference point that can be challenged.
In these situations, reimbursement begins to compress.
The structure of the NSA introduces a framework where weaker positioning becomes more visible and more consequential in how reimbursement is determined.
Where the opportunity still exists
Despite the changes, meaningful opportunities are still there.
Pre-service strategy continues to play a big part. How a case is positioned before treatment can influence how it is evaluated later, particularly when clinical complexity and access limitations are clearly established.
The IDR process, while structured, rewards well-developed cases. Providers who invest in documentation, market alignment, and narrative consistency tend to perform better.
There is also an advantage in understanding payer behavior within this framework. Patterns emerge over time, and those patterns can be used to inform how cases are built and when escalation is appropriate.
The opportunity remains, with outcomes now more closely tied to how effectively each case is executed.
The Valedo approach under the No Surprises Act
At Valedo, the NSA is approached as a structured system that can be actively managed and shaped to influence reimbursement outcomes.
The focus remains on controlling outcomes across the full lifecycle of a claim.
That includes:
Positioning cases effectively before care is delivered
Structuring claims to align with how payers evaluate them
Building strong, evidence-based submissions for negotiation and IDR
Each case is approached as a financial asset. The goal is to make sure that when it moves through the NSA framework, it does so with a clear and defensible position.
This reduces reliance on reactive processes and improves consistency across cases.
Reimbursement under the No Surprises Act requires a different approach
The No Surprises Act changed how out-of-network reimbursement works. It did not eliminate the ability to achieve strong financial outcomes.
What it did was remove informal mechanisms and replace them with a structured system. Providers who adapt to that system tend to perform more consistently. Those who rely on prior approaches often experience compression.
The difference comes down to how the process is managed.
At Valedo, this change is built into how cases are handled from the start. Strategy is applied before treatment, reinforced during claim execution, and carried through negotiation and resolution.
If your organization is still navigating the NSA as a compliance requirement, there is an opportunity to approach it differently.
